Tjoa Thian Song
Plus aucun poste en cours
Profil
Mr. Tjoa T.
Song is on the Board of Directors at Icon Bioscience, Inc.
Mr. Song also served on the board at Liquidmetal Technologies, Inc.
He received his undergraduate degree from the University of Texas and an MBA from the National University of Singapore.
Anciens postes connus de Tjoa Thian Song
| Sociétés | Poste | Fin |
|---|---|---|
Icon Bioscience, Inc.
 Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Directeur/Membre du Conseil | - |
| LIQUIDMETAL TECHNOLOGIES, INC. | Directeur/Membre du Conseil | - |
Formation de Tjoa Thian Song
| The University of Texas at Austin | Undergraduate Degree |
| National University of Singapore | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LIQUIDMETAL TECHNOLOGIES, INC. | Non-Energy Minerals |
| Entreprise privées | 1 |
|---|---|
Icon Bioscience, Inc.
Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Health Technology |